Denial Of Arbitration In Vaccine Pricing Class Suit Vacated; Discovery Ordered

Mealey's (October 31, 2019, 10:35 AM EDT) -- PHILADELPHIA — A Third Circuit U.S. Court of Appeals panel on Oct. 28 ruled that the summary judgment standard was appropriately applied by a trial court to a drug company’s motion for arbitration in a class suit over vaccine pricing but vacated the denial of motion and remanded for limited discovery on the issue of arbitrability (Sugartown Pediatrics, L.L.C., et al. v. Merck Sharp & Dohme Corp. [In re: Rotavirus Vaccines Antitrust Litigation], No. 19-1405, 3rd Cir., 2019 U.S. App. LEXIS 32286)....